Affiliation:
1. Endocrine Division Quest Diagnostics Nichols Institute San Juan Capistrano California USA
2. Department of Clinical Sciences Lund University Malmö Sweden
3. Department of Emergency and Internal Medicine Skåne University Hospital Malmö Sweden
Abstract
AbstractBackgroundInsulin resistance (IR) is associated with cardiovascular disease (CVD). However, insulin immunoassay variability and scarce research of the elderly have hindered the adoption of IR assessment for CVD prevention. We asked whether the probability of having IR [p(IR)]—derived from insulin and C‐peptide mass‐spectrometry assays—was associated with CVD in the elderly.MethodsA random cohort was drawn from MPP, a population‐based study of the elderly. After excluding those with missing data, CVD, or diabetes, 3645 participants (median age = 68) remained.ResultsDuring follow‐up (13.3 years), 794 incident CVD events were observed. p(IR) > 80% (n = 152) compared with p(IR) ≤ 80% was associated with incident CVD (HR = 1.51, 95% CI 1.12–2.05, p = 0.007) and CVD or all‐cause mortality (HR = 1.43, 95% CI 1.16–1.77, p = 0.0009) after adjusting for age, sex, hypertension, smoking, HDL‐cholesterol, total cholesterol, triglycerides, BMI, and prediabetes.ConclusionHigh p(IR) was associated with >50% greater risk of incident CVD. IR assessment in the elderly may be warranted.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献